I obtained my B.Sc. in Health Sciences and Technology with a focus in Medical Technology as well as a M.Sc. in Biomedical Engineering with a specialization in Molecular Bioengineering from the Swiss Federal Institute of Technology in Zurich (ETH Zürich).  Early in my bachelor’s degree, I pursued projects in Dr. Katrien De Bock’s lab, focusing on angiogenesis in the context of exercise and nutrition. I later joined Dr. Simone Schürle-Finke’s lab, specialized in robotic systems for biomedical applications, where I developed a drug delivery platform for solid tumor penetration utilizing magnetically responsive bacteria (magnetotactic bacteria) and force-responsive nanocarriers, creating a spatiotemporally controlled delivery approach. After my graduation, I joined lino Biotech, a spin-off company of ETH Zurich specializing in the development of a novel biosensing technology called focal molography. There, I was heavily involved in product design, and developed several products including a turn-key streptavidin chip and an assay for loading fraction determination of AAVs in complex samples. My current focus in Dr. Cheemeng Tan’s lab is developing a high-throughput platform for the development and functional assessment of synthetic vesicles for therapeutic applications.